R. Morrell

Tracking laboratory contamination by using a Bacillus cereus pseudoepidemic as an example

R. Morrell, B. Wasilauskas, 1992, Journal of clinical microbiology.

Clinical use of rifampicin during routine reporting of rifampicin susceptibilities: a lesson in selective reporting of antimicrobial susceptibility data.

R. Morrell, B. Wasilauskas, C. Steffee, 1997, The Journal of antimicrobial chemotherapy.

Performance of fungal blood cultures by using the Isolator collection system: is it cost-effective?

R. Morrell, B. Wasilauskas, C. Steffee, 1996, Journal of clinical microbiology.

An automated system for detecting nonadherence in laboratory testing and monitoring for myelosuppression in patients receiving self-administered oral chemotherapy.

J. Tooze, G. Lesser, R. Morrell, 2013, Journal of oncology practice.

Clinical comparison of the isolator and BacT/Alert aerobic blood culture systems

R. Morrell, B. Wasilauskas, 1995, Journal of clinical microbiology.

Inhibitory effect of the Isolator blood culture system on growth of Mycobacterium avium-M. intracellulare in BACTEC 12B bottles

R. Morrell, B. Wasilauskas, 1994, Journal of clinical microbiology.

Goals and Adverse Effects: Rate of Concordance Between Patients and Providers.

G. Russell, Olivia M. Riffle, B. Powell, 2019, Journal of oncology practice.